Clinical Trial Update: Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis [Phase 4]

View source ↗

Summary

This document reports the completion status of a Phase 4 trial evaluating Atazanavir or Lopinavir for HIV post-exposure prophylaxis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ATAZANAVIR (atazanavir)
• Lopinavir (lopinavir)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: HIV Infections | Phase 4 | Status: COMPLETED